PDS Biotechnology Reports Financial Results for the First Quarter 2020 and Provides Business Update
FLORHAM PARK, N.J., May 13, 2020 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel […]